Clinical Trials Browser

Phase 2 × Kidney Neoplasms × Imatinib Mesylate × Clear all

NCT00331409 2017-10-26

Everolimus and Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney Cancer

Phase 2 Completed

23 enrolled 11 charts

Carcinoma, Renal Cell, Kidney Neoplasms

NCT00323791 2009-12-11

Gemcitabine With or Without Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney Cancer

Phase 2 Terminated

Carcinoma, Renal Cell, Kidney Neoplasms